Emily K Moser (Emily Moser)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Cell Cycle Arrest

Immune Response

Endoplasmic Reticulum Stress

Top Venues

The Journal of experimental medicine

Proceedings of the National Academy of Sciences of the United States of America

Journal of virology

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Lei Wang, Yufeng Xiao, Yuewan Luo, Rohan P Master, Jiao Mo, Myung Chul Kim, Yi Liu, Chandra K Maharjan, Urvi M Patel, Umasankar De, Madison E Carelock, Tanzia Islam Tithi, Xiangming Li, Donald R Shaffer, Kevin R Guertin, Haoyang Zhuang, Emily K Moser, Keiran S M Smalley, Dong-Wen Lv, Daohong Zhou, Guangrong Zheng, Weizhou Zhang
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy. The Journal of experimental medicine 221 (3) (2024)
Yiping Wang, Mikayla Manzi, April Feswick, Lindsay Renshaw, Paula M Oliver, Scott A Tibbetts, Emily K Moser
B cell expression of E3 ubiquitin ligase Cul4b promotes chronic gammaherpesvirus infection in vivo . Journal of virology (2023)
Lindsay Renshaw, Peter Kim, Macaul Crici, Hossein Fazelinia, Lynn Spruce, Paula M Oliver, Emily K Moser
The Ubiquitin Ligase Itch Skews Light Zone Selection in Germinal Centers. Journal of immunology (Baltimore, Md. : 1950) (2023)
Yiping Wang, April Feswick, Vasiliki Apostolou, Petko M Petkov, Emily K Moser, Scott A Tibbetts
Gammaherpesvirus-mediated repression reveals EWSR1 to be a negative regulator of B cell responses. Proceedings of the National Academy of Sciences of the United States of America 119 (32) (2022)